19th March 2025
The Barts Cancer Institute (BCI), Queen Mary University of London, has been awarded the LEAF Bronze award for sustainability, achieving Bronze or Silver certification standards across each of our 15 laboratory sections.
Read more7th March 2025
Scientists have discovered a potential way to improve chemotherapy’s effect on ovarian cancer by manipulating specific immune cells around the tumour, potentially offering a way to help thousands of women with ovarian cancer benefit more from standard therapies and potentially delay relapses.
Read more26th February 2025
When Dr Alex Papachristodoulou joined our MSc programme at Barts Cancer Institute, Queen Mary University of London, he discovered his passion for cancer research and set out on a career path that led him to launch his own independent lab.
Read more14th February 2025
Scientists have discovered a new way to predict which tumours will become aggressive before they metastasise and spread around the body. The findings could help doctors spot which tumours are likely to be aggressive and cause metastatic cancer. They also open new avenues for treating cancer before it spreads.
Read more11th February 2025
Barts Cancer Institute, Queen Mary University of London will co-lead a ground-breaking collaboration, PharosAI, that aims to harness cutting-edge artificial intelligence (AI) and unlock decades of NHS cancer data. The UK government is committing £18.9 million to the project.
Read more4th February 2025
Barts Cancer Institute, Queen Mary Univerity of London, is delighted to announce the publication of a special commemorative book celebrating twenty years of cancer discoveries since the establishment of the institute.
Read more